Jae Chung
Family · Los Angeles, CANPI 1184053662
Payments from drug & device makers
Across 172 payments — averaging $21.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$426
- GSK$404
- Amgen$391
- Bayer$352
- Nestle Healthcare Nutrition Inc.$275
- Boehringer Ingelheim$272
- plus $2K from 13 others
What the payments were for
- Food & beverage$3,704100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 19 | $426 |
| GSK | 24 | $404 |
| Amgen | 15 | $391 |
| Bayer | 15 | $352 |
| Nestle Healthcare Nutrition Inc. | 12 | $275 |
| Boehringer Ingelheim | 12 | $272 |
| AstraZeneca | 12 | $259 |
| AbbVie | 16 | $250 |
| Novartis | 9 | $247 |
| Lilly USA, LLC | 10 | $200 |
| Radius Health, Inc. | 6 | $137 |
| Novo Nordisk | 5 | $111 |
| Eisai Inc. | 4 | $90 |
| Ardelyx, Inc. | 3 | $82 |
| Aimmune Therapeutics, Inc. | 3 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $46 |
| Ironwood Pharmaceuticals, Inc | 2 | $45 |
| IBSA Pharma Inc. | 2 | $38 |
| Exact Sciences | 1 | $15 |
How this compares
$3,716 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 389 | $288,480 |
| CreonLipase/Protease/Amylase | 210 | $249,681 |
| VascepaIcosapent Ethyl | 493 | $221,175 |
| TradjentaLinagliptin | 178 | $111,300 |
| JanuviaSitagliptin Phosphate | 138 | $99,863 |
| ZenpepLipase/Protease/Amylase | 91 | $98,600 |
| FarxigaDapagliflozin Propanediol | 139 | $95,049 |
| TrulicityDulaglutide | 70 | $82,035 |
| LinzessLinaclotide | 106 | $61,272 |
| KerendiaFinerenone | 77 | $60,782 |
| JanumetSitagliptin Phos/Metformin Hcl | 79 | $57,415 |
| OzempicSemaglutide | 38 | $37,058 |
| RestasisCyclosporine | 46 | $34,714 |
| ProliaDenosumab | 21 | $34,266 |
| EliquisApixaban | 35 | $26,637 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Jentadueto, Synjardy | $272 | $417,938597 claims |
| AbbVieCreon, Linzess, Restasis | $250 | $345,667362 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $200 | $104,69093 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $259 | $101,957150 claims |
| Aimmune Therapeutics, Inc.Zenpep | $75 | $98,60091 claims |
| BayerKerendia | $352 | $60,78277 claims |
| Novo NordiskOzempic, Rybelsus | $111 | $56,74756 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Shingrix | $404 | $36,71383 claims |
| AmgenProlia | $391 | $34,26621 claims |
| NovartisEntresto | $247 | $20,81526 claims |
| IBSA Pharma Inc.Licart | $38 | $18,99922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.
Other family in Los Angeles
- Annette ShonLos Angeles$406K
- Phyllis CasonLos Angeles$187K
- Theodore SolomonLos Angeles$131K
- Angela SarffLos Angeles$51K
- Karla MenjivarLos Angeles$36K
- Janet GripshoverLos Angeles$30K
- Jualynda SmithLos Angeles$28K
- Phoebedel ReyesLos Angeles$26K
- Lori RobertsonChino Hills$475K
- Nancy GardettoSan Diego$394K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.